Debut Bio’s biosynthesis platform provides a scalable biomanufacturing approach while eliminating the need for traditional precious metal catalysts and toxic reagents SAN DIEGO (PRWEB) SEPTEMBER 15, 2020 Debut...
Cell-free biology
Debut Biotechnology Closes $2.6M Seed Round to Bring Continuous Biomanufacturing of High-Value Molecules to Pharma
Debut Bio’s easy-to-use enzyme cartridges enable sustainable manufacturing of complex pharmaceuticals in an automated, continuous manufacturing system SAN DIEGO (PRWEB) January 07, 2020 Debut Biotechnology, a UC-Irvine...